Journal List > J Korean Ophthalmol Soc > v.48(8) > 1007903

Kim, Lee, Kim, and Lee: Central Corneal Thickness and Visual Field Progression in Primary Open-Angle Glaucoma

Abstract

Purpose

To find difference in the rate of visual field defect progression among primary open angle glaucoma (POAG) patients grouped according to central corneal thickness (CCT).

Methods

The medical records of 87 eyes of 87 POAG patients who received were on regular treatment and had a minimum of 5 years of longitudinal Humphrey automated visual field follow-up were reviewed retrospectively. The patients were divided into 4 quartile groups by CCT, and the correlations among clinical factors, such as intraocular pressure (IOP), and change in mean deviation (MD), were analyzed.

Results

The thinner cornea group showed a significant trend foward higher average, maximal, and yearly maximal IOP when the IOP was corrected by CCT (p<0.01), The rate of change in MD is significantly different; −0.33±0.6dB, −0.28±0.4dB, −0.09±0.2dB,-0.02±0.2dB starting with the thinnest cornea group (p=0.036). Correlation analysis revealed a significant correlation between CCT and the rate of change in MD (r=0.351, p=0.001).

Conclusions

In POAG patients who were on regular treatment at a tertiary referral hospital, patients with thinner cornea showed faster visual field defect progression.

References

1. Damji KF, Muni RH, Munger RM. Influence of corneal variables on accuracy of intraocular pressure measurements. J Glaucoma. 2003; 12:69–80.
2. Shah S, Chatterjee A, Mathai M, et al. Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology. 1999; 106:2154–60.
3. Ehlers N, Bramsen T, Sperling S. Applanation tonometer and central corneal thickness. Acta Ophthalmol. 1967; 77:734–40.
4. Whitacre MM, Stein RA, Hassanein K. The effect of corneal thickness on applanation tonometry. Am J Ophthalmol. 1993; 115:592–6.
crossref
5. Copt RP, Thomas R, Mermound A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol. 1999; 117:14–6.
crossref
6. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120:714–20.
7. Brandt JD, Beiser JA, Kass MA, et al. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology. 2001; 108:1779–88.
crossref
8. Kass MA, Hart WH Jr, Gorgon M, Miller JP. Risk factors favoring the development of glaucomatous visual field loss in ocular hypertension. Surv Ophthalmol. 1980; 25:155.
crossref
9. Herndon LW, Weizer JS, Stinnett SS. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol. 2004; 122:17–21.
crossref
10. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol. 2000; 44:367–408.
11. Congdon NG, Broman AT, Bandeen-Rochek , et al. Central corneal thickness and corneal hysteresis associated with glaucoma damage. Am J Ophthalmol. 2006; 141:868–75.
crossref
12. Hansen FK. A clinical study of the normal human central corneal thickness. Acta Ophthalmol. 1971; 49:82–9.
13. Shah S, Spedding C, Bhojwani R, et al. Assessment of the diurnal variation in central corneal thickness and intraocular pressure for patients with suspected glaucoma. Ophthalmology. 2000; 107:1191–3.
crossref
14. Argus WA. Ocular hypertension and central corneal thickness. Ophthalmology. 1995; 102:1810–2.
crossref
15. Medeiros FA, Sample PA, Zangwill LM, et al. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol. 2003; 136:805–13.
crossref
16. Kim JW, Chen PP. Central corneal pachymetry and visual field progress in patients with open-angle glaucoma. Ophthalmology. 2004; 111:2126–32.
17. Choi YJ, Kim JH, Sohn YH. Influence of central corneal thickness on diagnosis of glaucoma. J Korean Ophthalmol Soc. 2003; 44:2823–8.

Figure 1.
Scattergram of changes in mean deviation in automated visual field test and corrected intraocular pressure with central corneal thickness (Pearson correlation test, r=-0.302, p=0.004).
jkos-48-1088f1.tif

IOP=intraocular pressure in mm Hg; MD=mean deviation in dB in Humphrey automated perimetry.

Rate of MD change (dB/yr)=(final MD - initial MD) / follow-up years.

Figure 2.
Scattergram of central corneal thickness and change in mean deviation in automated visual field test (Pearson correlation test, r=0.351, p=0.001).
jkos-48-1088f2.tif

CCT=central corneal thickness in μm; MD=mean deviation in dB in Humphrey automated perimetry.

Rate of MD change (dB/yr)=(final MD - initial MD) / follow-up years.

Table 1.
Demographics of the patients
No. of patients (eyes) 87 (87)
Male:Female 59:28
Age, M±SD (range, years) 58.2±9.7 (40∼84)
  Laterality (Right : Left) 48:39
Numbers of patients with systemic diseases (%)
  Diabetic mellitus 18 (20.7)
  Hypertension 18 (20.7)
  Cardiovascular disease 2 (2.3)
  Thyroid disease 1 (11)
Follow up, M±SD (range, years) 7.2±2.7 (5∼20)
Numbers of surgery during follow-up period (%)
  Trabeculectomy 25 (28.7)
  Glaucoma implant surgery 3 (3.4)
  Phacoemulsification+PC-IOL 25 (28.7)
Central corneal thickness, M±SD (range, pm) 536.9±35.0 (440 ∼ 626)

PC-IOL=posterior chamber intraocular lens.

Table 2.
Patient characteristics grouped by central corneal thickness
(mean±SD)
Group (n) Group 1 (20) Group 2 (23) Group 3 (22) Group 4 (22) p-value
CCT <513 μm 513∼535 μm 536∼557 μm >557 μm
Follow up (years) 7.3±2.5 6.4±1.6 8.5±3.7 7.1±2.2 0.077
Age (years) 61.1±9.8 58.0±9.7 55.5±7.4 58.4±10.5 0.301
Sex (male/female) 14/6 15/8 17/5 13/9 0.630
Laterality (Right/Left) 12/8 8/15 14/8 14/8 0.153
Systemic diseases (No) 0.4±0.5 0.3±0.5 0.7±0.8 0.5±0.7 0.179
Number of surgery 0.8±1.2 0.7±0.8 0.5±0.9 0.6±0.9 0.857

one-way ANOVA test.

CCT=central corneal thickness.

Table 3.
Comparison of intraocular pressure course and changes of cup-disc ratio in 4 groups divided by central corneal thickness
(mean±SD)
Group (n) Group 1 (20) Group 2 (23) Group 3 (22) Group 4 (22) p-value
CCT <513 μm 513∼535 μm 536∼557 μm >557 μm
IOP on 1st visit 21.2±3.8 22.2±5.5 19.9±4.0 21.5±4.6 0.397
Glaucoma meds. 1.5±1.2 1.7±0.9 1.7±1.0 1.3±1.2 0.688
on 1st visit
Average IOP 17.4±1.7 17.1±2.4 16.9±1.9 18.5±2.2 0.052
Highest IOP 23.0±4.6 25.8±6.0 22.7±4.8 23.9±4.7 0.186
Yearly max IOP 19.2±3.6 19.8±2.6 18.3±2.3 19.9±2.5 0.210
Yearly variation 4.0±3.1 4.8±2.4 3.1±1.4 3.6±1.4 0.060
Average No. of 1.8±0.8 1.8±0.6 1.5±0.9 1.4±0.8 0.268
glaucoma meds.
Initial C/D ratio 0.78±0.2 0.80±0.2 0.77±0.1 0.69±0.2 0.121
Last C/D ratio 0.87±0.1 0.88±0.1 0.87±0.1 0.78±0.2 0.065
Change of C/D ratio 0.08±0.1 0.08±0.1 0.10±0.1 0.09±0.1 0.894

one-way ANOVA test.

IOP=intraocular pressure in mmHg; CCT=central corneal thickness.

Table 4.
Comparison of corrected intraocular pressure according to the central corneal thickness in 4 groups divided by central corneal thickness
(mean± SD)
Group (n) Group 1 (20) Group 2 (23) Group 3 (22) Group 4 (22) p-value
CCT <513 μm 513∼535 μm 536∼557 μm <557 μm
Average IOP 19.5±3.0 18.2±1.6 16.3±2.0 15.9±2.2 0.000
Highest IOP 26.5±6.1 25.1±4.8 22.2±4.9 21.6±4.8 0.005
Yearly maximal IOP 21.4±3.8 20.6±2.6 17.8±2.3 17.7±2.5 0.000

one-way ANOVA test.

IOP=intraocular pressure in mmHg; CCT=central corneal thickness.

Table 5.
Comparison of change in mean deviation in Humphrey automated visual field in 4 groups divided by central corneal thickness
(mean± SD)
Group (n) Group 1 (20) Group 2 (23) Group 3 (22) Group 4 (22) p-value
CCT <513 μm 513∼535 μm 536∼557 μm >557 μm
MD Initial -12.4±10.1 -11.0±8.5 -10.0±8.3 -6.0±7.1 0.089
MD Last -14.2±11.3 -12.9±9.3 -10.6±8.0 -6.1±7.2 0.022
MD Change -1.9±3.4 -1.9±3.2 -0.6±1.9 -0.2±1.3 0.056
MD Slope -0.33±0.6 -0.28±0.4 -0.09±0.2 -0.02±0.2 0.036

one-way ANOVA test.

MD=mean deviation in dB in Humphrey automated perimetry; CCT=central corneal thickness.

MD Slope: Rate of MD change (dB/yr)=(final MD - initial MD)/follow-up years.

TOOLS
Similar articles